Has Jo Herzog, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,332 in general payments to Jo Herzog, MD across 150 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jo Herzog, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jo Herzog, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jo Herzog, MD

Dermatology · Vestavia Hills, ALNPI 1295828309

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.5% of the total across 150 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Merz North America, Inc. at 45.1% of the total. 2025 is the largest year on record at $941, 6.1 times the $154 reported in 2019. That places this record below the midpoint for dermatology clinicians in AL, where the typical reported total is $4,251.

$4,332in general payments, 2019–2025

Across 150 payments — averaging $28.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merz North America, Inc.$2K
Galderma Laboratories, L.p.$702
AbbVie$334
Novartis$225
LEO Pharma Inc.$139
Amgen$131
plus $845 from 14 others

$3,537in research payments, 2019–2025

Across 2 payments — averaging $1768.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$4K

What the payments were for

Speaking & faculty fees$1503%
Food & beverage$4,18297%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merz North America, Inc.	54	$1,955
Galderma Laboratories, L.p.	19	$702
AbbVie	19	$334
Novartis	8	$225
LEO Pharma Inc.	6	$139
Amgen	6	$131
Incyte Corporation	5	$130
Arcutis Biotherapeutics, Inc.	7	$127
Kerecis Limited	3	$117
Johnson & Johnson	5	$99
Boehringer Ingelheim	4	$97
Mayne Pharma Commercial LLC	3	$56
Lilly USA, LLC	2	$44
Sanofi	1	$34
Pfizer	2	$33
Almirall LLC	2	$27
AstraZeneca	1	$23
Sun Pharmaceutical Industries Inc.	1	$23
Genentech USA, Inc.	1	$20
Bioventus LLC	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XEOMIN$588

How this compares

$4,332 in reported general payments places this provider in the 50th percentile of 168 dermatology providers in Alabama.

See all dermatology providers in Alabama →

Medicare billing

Part B allowed, 2024

$67,581

Medicare patients

292

Services billed

1,585

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Hyclate	132	$2,738
Triamcinolone Acetonide	119	$2,256
Imiquimod	53	$1,884
Ketoconazole	101	$1,793
Metronidazole	21	$1,368
Econazole Nitrate	27	$1,188
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc	31	$1,072
Clobetasol Propionate	13	$882
Betamethasone Dipropionate	12	$612
ValacyclovirValacyclovir Hcl	27	$486
Hydrocortisone	50	$462
Mupirocin	44	$401
Amoxicillin	14	$87

Paid to pharmacies, not to this prescriber.

Other dermatology in Vestavia Hills

John VanloockMobile$1.4M
James KrellBirmingham$944K
Julie HarperBirmingham$920K
Eric BaumGadsden$896K
Corey HartmanBirmingham$573K
Kevin NashAuburn$341K
Boni ElewskiBirmingham$271K
Tiffany MayoBirmingham$256K
Porcia LoveMontgomery$197K
Vlada GroysmanHoover$159K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →